Innovare

I do not price-gouge essential medicines. Experimental antiretrovirals, MTP kits, central nervous system stimulants, monoamine oxidase inhibitors, MOR-targeting drugs, and gabapentinoids are not sold to whoever will pay the most. Access should never depend on who has the deepest pockets.

Our aim is simple and practical: provide what people need. In the near term I am working toward free MTP kits and free PEP with express delivery. These are goals which align with our core principles, not a silly marketing ploy.

The first step in bodily self-defense is to recognize the harms and to know your rights. Learn what protections exist, then hold institutions accountable. Prohibiting access to drugs does not protect people. It forces them to live by the values and judgments of physicians, pharmacists, and regulators instead of their own.

In Sweden access to PEP and PrEP is limited, and medical termination of pregnancy remains difficult or impossible in many countries. That is not in your best interest; it actively undermines the right to self-determination.

Innovare is direct-action activism. I do this because access and bodily autonomy matter. Those who hate us are privileged to even be able to do so.

Psychostimulants have been studied for nearly a century for their ability to rapidly and profoundly lift low mood. Evidence suggests they can bring even severely intractable depression into remission, including cases resistant to MAOIs or ketamine therapy. Yet despite this long history and their demonstrated efficacy, these medications remain underused and under-researched in contemporary psychiatric practice.

Since the introduction of Benzedrine in 1932 [1], clinicians have prescribed stimulants such as amphetamine and, later, methylphenidate following the introduction of Ritalin, for depression and related conditions. These compounds remain among the first and most potent antidepressants ever developed, yet modern prescribing practices largely overlook their documented efficacy.

For many individuals with especially severe depression, they are sometimes regarded as nothing short of a miracle:

“At the six-month follow-up, the patient still endorsed a very significant relief of depressive symptoms. She stated that her mood is still very much improved, that she feels very stable on dextroamphetamine and amphetamine combination salts and even went as far as to call it “a wonder drug” for her.” (Small et al., 2022)

These drugs show evidence for alleviating core symptoms of depression, including psychomotor inhibition, lethargy, and persistent low mood, with measurable improvements often observed within hours. They may also prolong periods between depressive episodes in individuals with recurrent depression, showing remarkable efficacy even in the most treatment-resistant cases [3, 4, 5, 6]. In the study by Stotz, Woggon, and Angst (1999), no tolerance developed throughout the study period [3], challenging the common notion that long-term use necessarily leads to diminished response.

Evidence suggests that methylphenidate may lower the incidence of suicide attempts and self-harming behavior [7] and improve positive interpersonal perceptions in individuals experiencing dysphoria [8].

Despite these robust and clinically significant effects, psychostimulants remain underutilized in contemporary psychiatric practice, a neglect that is difficult to justify given their documented efficacy and safety. As highlighted by David Horgan:

“Why reject using any medication that may stop the relentless personal and family destruction of a ‘malignant sadness’ that may result in death? […] Would any inquiry accept that the risks of psychostimulants […] justify the psychiatrist in not telling intractably depressed or suicidal patients of their availability? […] patients have a right to be informed of all reasonable treatments […]”

Note: None of this is medical advice, of any sort. 🙂

Citations

1. WILBUR DL, MacLEAN AR, ALLEN EV. CLINICAL OBSERVATIONS ON THE EFFECT OF BENZEDRINE SULFATE: A STUDY OF PATIENTS WITH STATES OF CHRONIC EXHAUSTION, DEPRESSION AND PSYCHONEUROSIS. JAMA. 1937;109(8):549–554. doi:10.1001/jama.1937.02780340005003
2. Small TM, Dhat S, Faruqui Z. Dextroamphetamine-Amphetamine Augmentation in the Treatment of Treatment-Resistant Depression. Cureus. 2022 Aug 7;14(8):e27755. doi: 10.7759/cureus.27755. PMID: 36106259; PMCID: PMC9445411.
3. Stotz, G., Woggon, B., & Angst, J. (1999). Psychostimulants in the therapy of treatment-resistant depression Review of the literature and findings from a retrospective study in 65 depressed patients. Dialogues in Clinical Neuroscience, 1(3), 165–174. https://doi.org/10.31887/DCNS.1999.1.3/gstotz
4. Woods SW, Tesar GE, Murray GB, Cassem NH. Psychostimulant treatment of depressive disorders secondary to medical illness. J Clin Psychiatry. 1986 Jan;47(1):12-5.
5. Owens, D.A.. (2007). The Use of Methylphenidate for Depression in Palliative Care: A Case Study. Journal of Hospice and Palliative Nursing. 9. 236-237. 10.1097/01.NJH.0000289667.08914.39.
6. Wagner GJ, Rabkin JG, Rabkin R. Dextroamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study. J Psychosom Res. 1997 Apr;42(4):407-11. doi: 10.1016/s0022-3999(96)00366-2.
7. Rohde C, Brink P, Østergaard SD, Nielsen J. The use of stimulants in depression: Results from a self-controlled register study. Aust N Z J Psychiatry. 2020 Aug;54(8):808-817. doi: 10.1177/0004867420924076. Epub 2020 May 23.
8. Janowsky DS. Depression and dysphoria effects on the interpersonal perception of negative and positive moods and caring relationships: effects of antidepressants, amphetamine, and methylphenidate. Curr Psychiatry Rep. 2003 Dec;5(6):451-9. doi: 10.1007/s11920-003-0084-3

Innovare exists to bring access to medicines and medical technologies to those who need them but do not have them. Our goal is to empower people to take ownership of their own bodies, to protect bodily autonomy, and to make the right to repair a reality when it comes to understanding and advancing the science of your own health.I try to keep prices as fair and accessible as possible throughout the year, even when profit margins are very small.

it’s an unfortunate relity for some, that’s often overlooked by those fortunate enough.

During Christmas — or Yule, for those who celebrate it — prices are lowered even further. This is not about sales tactics, but about making access easier when people are already under financial pressure. Every order matters to me, not just financially but personally. I care about the people behind them.

Innovare is built on the belief that access to knowledge, tools, and medicines should not be reserved for only those with money or institutional backing. Friends and community are among the most valuable things we have.

Swedish authorities, pharmaceutical companies, the press, and alike would probably hate this project, or initiative. To those, I say to please go fuck yourself, for making my closest friends have to suffer a completely avoidable despair you’ve undoubtedly put them (and many others) through.

Innovare has always been within bounds of applicable legislations of Sweden. Go whine elsewhere. :^) Any complaints? Send us a message using the legal channel on the contact page.

Real progress happens when people support each other, share resources, and look out for one another. That sense of trust and mutual respect matters more than profit.I have seen firsthand how difficult it can be to struggle while watching people you care about struggle too. I never want Innovare to feel like “yet-another-supplier”, instead that your research needs are actually met by us (or, well, me!).

Innovare has always advocated for you, and your right to self-determination. And we will continue to, until our inevitable end.

I sincerely appreciate everyone who visits, supports, or places an order (but it’s never an obligation). I do not have the resources of larger vendors, and some projects may take time, but I always do my best with what I have. Thank you for your patience and understanding.

If you have read this far and genuinely cannot afford to place an order, you are welcome to contact me and briefly explain your situation. I cannot promise help in every case, and I must be careful as trust can be abused, but I will always try my best within my limited means.

Innovare shall continue to grow, and help others! Helping people is de principio of our work, and the foundation of what keeps us going. <3

Relevant

Four Thieves Vinegar Collective

Elysian is one of the newest additions to our assortment. It’s not a single product, but a series, starting with our signature serenity shots, tonics, and capsules. Each addition is designed to expand the range of options available to our community.

Elysian is our premium yet affordable product range. It exists so we can support every single one of our amazing researchers and their needs. Leaving nobody behind, even when it would be easier or more profitable to do so.

Every formula is carefully developed in-house using thorough expertise and experimental experience. We put significant time, effort, and energy to every composition to ensure the highest quality. None of our formulations are white-label, and we intend to keep it that way. Compositions may evolve over time, but our commitment is always to maintain best-in-class quality.

As the series grows, we hope to offer (conceptualized product names)

• RLS-class shots for time-sensitive applications.
• Thymoleptic-inspired tonics and capsules.
• Neurotonic: the best-in-class, in neuropathy science.
• Awake: staying up for extended periods of time, can feel excruciating, both mentally and on your body. Perhaps you work late-night shifts, and so on. It can feel exhausting both mentally, and physically, if you’re not used to it. Perhaps you drive a bus, truck, or just need.to stay awake for a car-drive. You know how much of a pain in the ass it can be at times. Any mishaps, and you could be part of the statistics yourself. However, we hope to make that be a thing of the past.
• Joint-lubricant: our chronic pain sufferers shouldn’t have to go without adequate relief–ever! The mischiefs of public medicine has failed so many of you.

(Disclaimer: All products and descriptions are for informational purposes only. They are not intended for human or in-vitro use and do not constitute treatment, prevention, or cure of any condition. Any mention of expected properties refers only to the included APIs and should not be interpreted as claims regarding effects or suitability.)

We’re not just another nootropics or API vendor, and our capacity is limited. But we put care and integrity first, striving to do our best in a market too often dominated by quick profits at the expense of others’ well-being.

We love hearing from our community and sincerely appreciate every one of our customers, and your trust means everything to us!

Elysian is an ongoing project and a forward-looking vision for Innovare.bio.

We solely exist for you, doing what so’calĺed “healthcare” couldn’t or neglected tö—it’s very much possible. May none be, or have to go without adequate relief!

Merry Christmas, or Yule/Jul!
—The Innovare Team <3

Who are we

Innovare is a small, steadily growing project built from the ground up by one single individual, without outside funding or backing. It began as a response to the neglect and unnecessary suffering caused by modern psychiatry, driven by the belief that meaningful progress often starts where institutions fall short.

The evidence gap

The end of the so-called “psychopharmacology era” left a void in the study and development of truly effective therapeutics. Today, nearly half of all clinical trials remain unpublished (AllTrials), leaving much of the evidence in the shadows.

Those that do get published often suffer serious methodological flaws and are subject to publication bias, making their findings largely unreliable—and in some cases, deliberately distorted, as with the infamous Study 329.

“46 (9%) of 522 trials were rated as high risk of bias, 380 (73%) trials as moderate, and 96 (18%) as low; and the certainty of evidence was moderate to very low.” – Cipriani et al., 2018

Why this matters

The abandonment and reluctance of many psychiatrists to use well-established and proven psychopharmaceuticals, as outlined by Ken Gillman, has left countless people enduring completely avoidable suffering (myself included).

To expand on the last part: I am very familiar with, and have extensive first-hand experience of, what it is like to live with psychiatric ailments such as severe depression and anxiety. I also have people close to me who have suffered the harms of contemporary psychiatry. These are not pretty disorders by any means. They cause immense suffering to the patient. I battle overwhelming guilt, a constant sense of inadequacy and persecutory delusions (among other things) for nearly every waking moment of the day.

Our work primarily serves academic researchers and independent citizen scientists, aiming to connect with those who share the same curiosity and values: that personal autonomy matters, that knowledge should be free, and that everyone should have access to the means of conducting their own research.

Driving meaningful progress and relief to those who feel they have been betrayed by contemporary medicine, and seeing my work and efforts pay off, is one of the greatest feelings there is.

Innovare won’t exist forever. But I hope that somebody continues building on the concept, even in the instance of an inevitable cease of operations.

It’s been confirmed! After a long wait, we will soon be able to offer Prolintane.HCl.

Prolintane hasn’t been available on the research chemical market for some time, largely due to government oversight and restrictions on its manufacture in Asia. That’s why we’re glad to be able to offer it.

Prolintane should be available for sale by late October – November.

As always, our goal is to keep things transparent, fair, and accessible to those who genuinely care about these compounds. If that’s you, you know what to do. 🙂

Update on the Phenelzine fiasco

As some of you have likely noticed, Phenelzine Sulfate has been out of stock for some time. If you placed a backorder, you may have been told it would ship during week 27—but unfortunately, that didn’t happen. I want to sincerely apologize for both the delay and the repeatedly postponed restock dates. I understand how frustrating this has been and truly appreciate your patience.

Timeline of events

So it appears we have effectively lost 100g of Phenelzine Sulfate, presumably to customs, though we cannot be certain. What makes the situation more complicated is that around the same time, the origin carrier for the trans-ISRIB we had also ordered—also ordered from the same supplier—pinged that it arrived in Sweden. But there was never any confirmation from PostNord that it had been accepted (or rejected for that matter), and we haven’t heard anything about it since July 4.

Other updates

• As of June 2025, we’ve added UPS shipping options across most delivery zones.
• As of 24 July 2025, untracked shipping is no longer available for non-domestic export orders over 100 EUR.